Reaction
Oligodipsia reporting signals
As of the last recalculation, Oligodipsia appears in 227 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 109.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Palivizumab | 17 | 109.6 | 109.7 |
| Acalabrutinib | 4 | 30.8 | 30.8 |